Cardia Bioplastics Announces Collaboration with Nestle to Reduce Environmental Impact of Packaging

By Cardia Bioplastics, PRNE
Sunday, December 5, 2010

MELBOURNE, Australia, December 6, 2010 - Cardia Bioplastics announces its collaboration with Nestle S.A., the
largest Fast Moving Consumer Goods company in the world, to reduce the
environmental impact of packaging.

Cardia Bioplastics Managing Director Dr Frank Glatz said: "Collaborating
with Nestle presents an exciting opportunity to develop high performance
packaging with lower environmental impact. In addition to offering a product
with beneficial environmental profile and full food safety compliance,
delivering superior packaging performance through the product life cycle is a
key criterion for success."

"Our proprietary multi-layer flexible film and rigid packaging
developments are important offerings in meeting demanding packaging
performance requirements," he said.

Cardia is well positioned to benefit from the trend towards sustainable
packaging. It offers customers the choice of using sustainable Cardia
Biohybrid(TM) technology (less oil, lower carbon foot print) or compostable
technology (delivering certified compostability to international standards)
for their packaging or plastic product solutions. The company's materials are
suitable for a broad range of packaging applications, including flexible
film, injection moulding, blow moulding, foam, and extrusion and coating

About Cardia Bioplastics

Cardia Bioplastics Limited (ASX CODE: CNN), through its 100% owned
subsidiary Cardia Bioplastics (Australia) Pty Ltd, develops, manufactures and
markets its patented renewable resource based materials and finished products
derived from Cardia's proprietary technology for the global packaging and
plastic products industries. The company holds a strong patent portfolio and
its growth is fuelled by the global trend towards sustainable packaging.
Established in Australia in 2002 as Biograde, the company Headquarters and
Global Applications Development Centre is in Melbourne, Australia. The
Product Development Centre and manufacturing plant is in Nanjing, China.
There are Cardia Bioplastics offices in the Americas, Europe, Malaysia and
China, and a network of leading distributors across the Americas, Asia and
Europe. Visit

    Further information: Dr Frank Glatz
                         Managing Director
                         Cardia Bioplastics

                         Barry Oosthuizen
                         Communication Advisor
                         Cardia Bioplastics

Dr Frank Glatz, Managing Director, Cardia Bioplastics, +61-400-930-530, or Barry Oosthuizen, Communication Advisor, Cardia Bioplastics, +61-413-185-135

will not be displayed